Role of 2-D echocardiography in detecting cardiovascular abnormalities in chronic kidney disease patients: Case series of 50 chronic kidney disease patients

Saxena, Nishant; Dhamija, Jas Pal; Saxena, Shubhi
January 2017
International Archives of Integrated Medicine;Jan2017, Vol. 4 Issue 1, p122
Academic Journal
Background: Chronic kidney disease is a major public health problem worldwide with continuously increasing incidence and prevalence. Diabetes and hypertension are the leading causes of chronic kidney disease worldwide, whereas hypertension is a cause as well as effect of chronic kidney disease. Objectives: To evaluate and analyze the echocardiographic changes in the end stage renal disease patients on maintenance haemodialysis by the help of 2-D echocardiography. Materials and methods: End stage renal disease (ESRD) patients who were on maintenance haemodialysis for at least 3 months, in MG hospital were included in the study. We performed 2-Dechocardiography in 50 ESRD patients during inter-dialytic period. Patients with clinical evidence of coronary artery disease, previous history of hypertension, valvular heart disease, congenital heart disease and pericardial effusion were excluded from this study. Results: out of 50 chronic kidney disease patients, echocardiography revealed LVH in 29 (58%) patients, LVDD in 25(50%) patients, pericardial effusion in 10 (20%) patients, pulmonary hypertension in 23(46%) patients, dilated left atrium in 14(28%) patients, dilated left ventricle in 4 (8%) patients and regional wall motion abnormalities in 3 (6%) patients. Hypertension was present in 46 (92%) out of 50 CKD patients out of which LVH was in 29 patients. Severe Anaemia was present in 10 (20%) patients. Conclusion: LV diastolic dysfunction and left ventricular hypertrophy were the most common and significant echocardiographic findings among 50 CKD patients. There was statistically significant correlation between anaemia and the presence of left ventricular hypertrophy and positive correlation between presence of hypertension and left ventricular hypertrophy.


Related Articles

  • A Comparative Study on Cardiac Profile among Patients of Acute and Chronic Renal Failure in a Tertiary Hospital of Orissa. Mishra, Prahallad Chandra; Jena, Sipra Komal // Indian Journal of Public Health Research & Development;Jan-Mar2014, Vol. 5 Issue 1, p10 

    Background: Cardiac changes are very commonly seen in both acute & chronic renal failure. The occurrence of cardiac failure or myocardial infarction prior to starting dialysis is an important prognostic factor. Therefore early detection of these factors are important so that the fatal outcomes...

  • STUDY REGARDING THE CHRONIC RENAL FAILURE IN BRASOV COUNTY BETWEEN 2000 AND 2009 - FROM EPIDEMIOLOGY DATE TO AN INFORMATICS' SYSTEM. BĂLESCU, A.; NEDELCU, L.; ROGOZEA, L. // Bulletin of the Transilvania University of Brasov, Seriels VI: M;2010, Vol. 3 Issue 52, p79 

    The chronic renal failure (CRF) is a public health issue. This illness is under diagnosed or belated diagnosed in advanced stages with severe complications, influencing the means to slow the disease progression, the only way to survive being the substitution of the renal. Recent studies show...

  • Body mass index trend in haemodialysis patients: the shift of nutritional disorders in two Italian regions. Postorino, Maurizio; Mancini, Elena; D'Arrigo, Graziella; Marino, Carmela; Vilasi, Antonio; Tripepi, Giovanni; Gallus, Silvano; Lugo, Alessandra; Santoro, Antonio; Zoccali, Carmine // Nephrology Dialysis Transplantation;Oct2016, Vol. 31 Issue 10, p1699 

    Background. In the USA, the increase in the prevalence of obesity in the general population has been accompanied by a marked increase in the prevalence and incidence of obesity in the dialysis population. However, secular trends of body mass index (BMI) have not been investigated in European...

  • EPO Resistance May Predict Heart Problems in HD Patients.  // Renal & Urology News;Apr2012, Vol. 11 Issue 4, p30 

    The article reports that the early detection of erythropoietin (EPO) resistance could help clinicians predict cardiovascular risk (CV) in hemodialysis (HD) patients.

  • Heart imaging gets faster, clearer. Wiebusch, Bruce // Design News;6/4/2001, Vol. 57 Issue 11, p64 

    Discusses imaging technologies for diagnosing heart disease. Capabilities of the OptiGo point of care ultrasound device; Information on computed tomography technology.

  • Echocardiography has potential to evaluate cardiac toxicity.  // British Journal of Hospital Medicine (17508460);Jan2012, Vol. 73 Issue 1, p8 

    The article reports two studies from the EUROECHO and other Imaging Modalities 2011 Congress, which used echocardiography to examine signs of adverse effects of trastuzumab, and the role of angiotensin-converting enzyme (ACE) inhibitors and statins on the hearts of cancer patients, respectively.

  • Cardiovascular Involvement in Children with Osteogenesis Imperfecta. Karamifar, Hamdollah; Ilkhanipoor, Homa; Ajami, Gholamhossein; Karamizadeh, Zohreh; Amirhakimi, Gholamhossein; Shakiba, Ali-Mohammad // Iranian Journal of Pediatrics;Oct2013, Vol. 23 Issue 5, p513 

    Objective: Osteogenesis imperfecta is a hereditary disease resulting from mutation in type I procollagen genes. One of the extra skeletal manifestations of this disease is cardiac involvement. The prevalence of cardiac involvement is still unknown in the children with osteogenesis imperfecta....

  • CARDIOVASCULAR RISK PROFILES IN A COHORT OF NEW DIAGNOSIS OF TYPE 2 DIABETES. STUDY OF THE CASTILLA Y LEÓN SENTINEL NETWORK. Alonso, T. V; Costa, M. G.; Alonso, J. E. L.; Arribas, S. F.; Sanz, R. A. // Journal of Epidemiology & Community Health;Aug2004 Supplement 1, Vol. 58, pA123 

    Diabetes type 2 is one of the main health problems in industrialized countries. As a risk factor for cardiovascular diseases, a risk profile of patients at diagnosis is essential in secondary prevention, therapy and prognosis. The objective of this communication is to describe this...

  • Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Stefoni, Sergio; Cianciolo, Giuseppe; Donati, Gabriele; Dormi, Ada; Silvestri, Maria Grazia; Colì, Luigi; De Pascalis, Antonio; Iannelli, Sandra // Kidney International;Jan2002, Vol. 61 Issue 1, p324 

    Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.. Background: It is thought that transforming growth factor-β1 (TGF-β1) might be a key inhibitor of atherogenesis in non-uremic patients. We evaluated the intra- and post-dialytic serum levels of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics